First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
From inflation and regulatory issues to claims automation and the evolving workforce, experts weigh in with unique insight across the P&C l
Independent Medical Exams (IMEs) can be a highly effective tool for looking at what is happening on a claim and help provide a strategy for timely
As a claims professional, we recognize you’re encountering new daily challenges. We want you to know that Genex is here to help.
How many of us have medicine cabinets where we store our “you never know” items?
While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for pot
Company continues to add to its growing portfolio of issued U.S.